Drug ID: | NPD7527 |
Drug Name: | |
Molecular Formula: | C30H53N3O6 |
Canonical SMILES: | COCCCOc1cc(ccc1OC)C[C@H](C(C)C)C[C@@H]([C@H](C[C@@H](C(=NCC(C(=N)O)(C)C)O)C(C)C)O)N |
Standard InCHI: | InChI=1S/C30H53N3O6/c1-19(2)22(14-21-10-11-26(38-8)27(15-21)39-13-9-12-37-7)16-24(31)25(34)17-23(20(3)4)28(35)33-18-30(5,6)29(32)36/h10-11,15,19-20,22-25,34H,9,12-14,16-18,31H2,1-8H3,(H2,32,36)(H,33,35)/t22-,23+,24-,25-/m0/s1 |
Standard InCHIKey: | UXOWGYHJODZGMF-NDBXHCKUSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNCL001713 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 23231644 |
ChEBI | |
CAS Number |
Molecular Weight | 551.39 |
ALogP | 0.2323 |
MLogP | 3.77 |
XLogP | 5.14 |
HDA | 7 |
HBD | 5 |
Rotatable Bonds | 31 |
TPSA | 150.61 |
RO5 Violation | 2 |